Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 13

1.

RNA Polyadenylation

The enzymatic addition of a sequence of adenylyl residues at the 3' end of an RNA molecule. [from NCI]

MedGen UID:
215435
Concept ID:
C0949765
Molecular Function
2.

Glucosamine

amino sugar derivative of glucose, substituted at the 2 position, occurring in glycosaminoglycans and a variety of complex polysaccharides such as blood group substances. [from CRISP]

MedGen UID:
6622
Concept ID:
C0017718
Organic Chemical; Pharmacologic Substance
3.

Error occurred: cannot get document summary

ID:
1462882

4.

Accumulation

A state characterized by the gradual increase in entities or substances. [from NCI]

MedGen UID:
883922
Concept ID:
C4055506
Finding
5.

Absence

MedGen UID:
739164
Concept ID:
C1689985
Anatomical Abnormality
6.

Phosphate

PO4(3-). [from CRISP]

MedGen UID:
737350
Concept ID:
C1601799
Element, Ion, or Isotope; Pharmacologic Substance
7.

Pulmonary alveolar proteinosis acquired

Pulmonary alveolar proteinosis is a pathologic entity characterized by intraalveolar surfactant accumulation. There are 3 clinically distinct forms: hereditary (usually congenital), secondary, and acquired. The acquired form of pulmonary alveolar proteinosis is the most common form, accounting for approximately 90% of cases. The mean age at diagnosis is 39 years and it is associated with smoking in 72% of cases. The estimated incidence and prevalence are 0.36 and 3.70 cases per million, respectively (Trapnell et al., 2003; Seymour and Presneill, 2002). Secondary pulmonary alveolar proteinosis develops in association with conditions involving functional impairment or reduced numbers of alveolar macrophages. Such conditions include some hematologic cancers, pharmacologic immunosuppression, inhalation of inorganic dust or toxic fumes, and certain infections. Congenital pulmonary alveolar proteinosis is a rare, severe, often fatal disorder of newborns associated with pulmonary surfactant metabolism dysfunction caused by mutations in genes involved in surfactant metabolism (see, e.g., SMDP1, 265120) (Trapnell et al., 2003). See 300770 for information on congenital PAP due to CSF2RA (306250) deficiency. [from OMIM]

MedGen UID:
410079
Concept ID:
C1970472
Disease or Syndrome
8.

Pituitary adenoma predisposition

MedGen UID:
354959
Concept ID:
C1863340
Finding
9.

Pulmonary alveolar proteinosis

MedGen UID:
18760
Concept ID:
C0034050
Disease or Syndrome
10.

Xicil

MedGen UID:
291380
Concept ID:
C1567630
Organic Chemical; Pharmacologic Substance
11.

Hespercorbin

MedGen UID:
291379
Concept ID:
C1567629
Organic Chemical; Pharmacologic Substance
12.

Dona

MedGen UID:
291378
Concept ID:
C1567628
Organic Chemical; Pharmacologic Substance
13.

Glucose-6-phosphate

An ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (Stedman, 26th ed) [from MeSH]

MedGen UID:
30772
Concept ID:
C0061418
Biologically Active Substance; Organic Chemical; Pharmacologic Substance
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center